These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
761 related items for PubMed ID: 25182250
1. Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial). Darkner S, Chen X, Hansen J, Pehrson S, Johannessen A, Nielsen JB, Svendsen JH. Eur Heart J; 2014 Dec 14; 35(47):3356-64. PubMed ID: 25182250 [Abstract] [Full Text] [Related]
2. QT as a predictor of recurrence after atrial fibrillation ablation and the impact of amiodarone: results from the placebo-controlled AMIO-CAT trial. Diederichsen SZ, Darkner S, Chen X, Johannessen A, Pehrson S, Hansen J, Svendsen JH. Europace; 2019 Jul 01; 21(7):1055-1062. PubMed ID: 30843038 [Abstract] [Full Text] [Related]
3. Natriuretic Propeptides as Markers of Atrial Fibrillation Burden and Recurrence (from the AMIO-CAT Trial). Darkner S, Goetze JP, Chen X, Henningsen K, Pehrson S, Svendsen JH. Am J Cardiol; 2017 Oct 15; 120(8):1309-1315. PubMed ID: 28865890 [Abstract] [Full Text] [Related]
4. Catheter ablation vs. amiodarone plus losartan for prevention of atrial fibrillation recurrence in patients with paroxysmal atrial fibrillation. Lan X, Su L, Ling Z, Liu Z, Wu J, Yang X, Zrenner B, Yin Y. Eur J Clin Invest; 2009 Aug 15; 39(8):657-63. PubMed ID: 19490069 [Abstract] [Full Text] [Related]
5. Catheter ablation of persistent atrial fibrillation : Beneficial effect of a short-term adjunctive amiodarone therapy on the long-term outcome. Kettering K, Gramley F. Herzschrittmacherther Elektrophysiol; 2018 Mar 15; 29(1):133-140. PubMed ID: 28447159 [Abstract] [Full Text] [Related]
7. Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial. Di Biase L, Mohanty P, Mohanty S, Santangeli P, Trivedi C, Lakkireddy D, Reddy M, Jais P, Themistoclakis S, Dello Russo A, Casella M, Pelargonio G, Narducci ML, Schweikert R, Neuzil P, Sanchez J, Horton R, Beheiry S, Hongo R, Hao S, Rossillo A, Forleo G, Tondo C, Burkhardt JD, Haissaguerre M, Natale A. Circulation; 2016 Apr 26; 133(17):1637-44. PubMed ID: 27029350 [Abstract] [Full Text] [Related]
8. Safety and efficacy of early radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation complicated with amiodarone-induced thyrotoxicosis. Wang M, Cai S, Sun L, Zhao Q, Feng W. Cardiol J; 2016 Apr 26; 23(4):416-21. PubMed ID: 27296156 [Abstract] [Full Text] [Related]
10. PulmOnary vein isolation With vs. without continued antiarrhythmic Drug trEatment in subjects with Recurrent Atrial Fibrillation (POWDER AF): results from a multicentre randomized trial. Duytschaever M, Demolder A, Phlips T, Sarkozy A, El Haddad M, Taghji P, Knecht S, Tavernier R, Vandekerckhove Y, De Potter T. Eur Heart J; 2018 Apr 21; 39(16):1429-1437. PubMed ID: 29211857 [Abstract] [Full Text] [Related]
12. Does a blanking period after pulmonary vein isolation impact long-term results? Results after 55 months of follow-up. Lodziński P, Kiliszek M, Koźluk E, Piątkowska A, Balsam P, Kochanowski J, Scisło P, Piątkowski R, Opolski G. Cardiol J; 2014 Apr 21; 21(4):384-91. PubMed ID: 24142681 [Abstract] [Full Text] [Related]
14. Efficacy of Antiarrhythmic Drugs Short-Term Use After Catheter Ablation for Atrial Fibrillation (EAST-AF) trial. Kaitani K, Inoue K, Kobori A, Nakazawa Y, Ozawa T, Kurotobi T, Morishima I, Miura F, Watanabe T, Masuda M, Naito M, Fujimoto H, Nishida T, Furukawa Y, Shirayama T, Tanaka M, Okajima K, Yao T, Egami Y, Satomi K, Noda T, Miyamoto K, Haruna T, Kawaji T, Yoshizawa T, Toyota T, Yahata M, Nakai K, Sugiyama H, Higashi Y, Ito M, Horie M, Kusano KF, Shimizu W, Kamakura S, Morimoto T, Kimura T, Shizuta S, EAST-AF Trial Investigators. Eur Heart J; 2016 Feb 14; 37(7):610-8. PubMed ID: 26417061 [Abstract] [Full Text] [Related]
15. Clinical efficacy of irrigated catheter application of amiodarone during ablation of persistent atrial fibrillation. Huang X, Chen Y, Huang Y, Zhao H, Chen Y, He L, Liu S, Shee V, Xu D, Peng J. Clin Cardiol; 2017 Dec 14; 40(12):1333-1338. PubMed ID: 29247513 [Abstract] [Full Text] [Related]
16. Catheter ablation of paroxysmal atrial fibrillation in patients with previous amiodarone-induced hyperthyroidism: a case-control study. Mikhaylov EN, Orshanskaya VS, Lebedev AD, Szili-Torok T, Lebedev DS. J Cardiovasc Electrophysiol; 2013 Aug 14; 24(8):888-93. PubMed ID: 23574390 [Abstract] [Full Text] [Related]
17. Optimal rhythm-control strategy for recurrent atrial tachycardia after catheter ablation of persistent atrial fibrillation: a randomized clinical trial. Zhang XD, Gu J, Jiang WF, Zhao L, Zhou L, Wang YL, Liu YG, Liu X. Eur Heart J; 2014 May 21; 35(20):1327-34. PubMed ID: 24497338 [Abstract] [Full Text] [Related]
18. Prediction of long-term outcomes of catheter ablation of persistent atrial fibrillation by parameters of preablation DC cardioversion. Kang JH, Lee DI, Kim S, Kim MN, Park YM, Ban JE, Choi JI, Lim HE, Park SW, Kim YH. J Cardiovasc Electrophysiol; 2012 Nov 21; 23(11):1165-70. PubMed ID: 22882453 [Abstract] [Full Text] [Related]
19. Arrhythmias: Amiodarone fails to lower AF recurrence in AMIO-CAT trial. Huynh K. Nat Rev Cardiol; 2014 Nov 21; 11(11):623. PubMed ID: 25245831 [No Abstract] [Full Text] [Related]